The Cooperative Re-Engagement Controlled Trial (CoRECT)

The summary for the The Cooperative Re-Engagement Controlled Trial (CoRECT) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.

The Cooperative Re-Engagement Controlled Trial (CoRECT): HIV antiretroviral therapy (ART) can durably suppress the plasma HIV viral load which restores and preserves immunologic function. Effective ART improves individual survival and quality of life and dramatically reduces further HIV transmission making it a priority for both individual health and community public health. Within the United States, the largest lost opportunity to achieve a suppressed viral load occurs among individuals who have failed linkage to or retention in HIV medical care. Health department demonstration projects have suggested that good partnerships and information exchange between health departments and HIV clinics are essential to linkage/re-engagement programs. The Cooperative Re-Engagement Controlled Trial (CoRECT) will evaluate an intervention to identify HIV-infected persons who are out-of-care and engage them in HIV care. Health department laboratory surveillance data and clinic appointment data will be shared at monthly case conferences to define recent out-of-care HIV infected individuals. These individuals will be randomized to receive an active health department field services intervention or usual linkage and engagement in care services. The active intervention activities will include field services to locate, contact, and provide assistance, including a same-day appointment to access HIV medical care. CoRECT will evaluate if the active intervention resulted in increased re-engagement in care, retention in care, and HIV viral load suppression as compared with usual linkage and engagement in care services. Ultimately the trial will demonstrate the feasibility of a joint health department – clinic intervention to identify recently out-of-care individuals and the effectiveness of an active health department intervention to (re-)engage these individuals in HIV medical care.

Federal Grant Title:	The Cooperative Re-Engagement Controlled Trial (CoRECT)
Federal Agency Name:	Centers for Disease Control and Prevention
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-PS-14-001
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.943
CFDA Descriptions:	Epidemiologic Research Studies of Acquired Immunodeficiency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) Infec
Current Application Deadline:	Jan 16, 2014 Letter of Intent Due Date: December
Original Application Deadline:	Jan 16, 2014 Letter of Intent Due Date: December
Posted Date:	Nov 18, 2013
Creation Date:	Nov 18, 2013
Archive Date:	Feb 15, 2014
Total Program Funding:	$6,900,000
Maximum Federal Grant Award:	$2,300,000
Minimum Federal Grant Award:	$2,000,000
Expected Number of Awards:	3
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: The following organizations are eligible to apply:
Competition is limited to state, local, and territorial health departments that are independently funded by CDC to perform HIV surveillance or their Bona Fide Agents. Funding decisions may also consider geographic diversity (e.g., applications that increase the diversity of geographic regions defined by the Department of Health and Human Services (http://www.hhs.gov/about/regionmap.html) represented in the program in order to maximize the program’s flexibility in addressing evolving public health research needs related to HIV that may vary by geographic region. Competition is further limited to health departments who meet the three special eligibility criteria listed in Section III.3 below.
3. Special Eligibility Requirements:
a. Applicants must have complete HIV laboratory reporting of CD4 and viral load test results, defined as follows3:
i. The jurisdiction’s laws/regulations require the reporting of all CD4 and viral load results to the state/city health department
ii. A minimum of 95% of HIV-related test results from laboratories that perform HIV-related testing for each area are being reported to the state/city health department
iii. The jurisdiction is reporting at least 95% of all CD4 and viral load test results to CDC as of this application’s deadline date.
b. Applicants may not be a grantee of The Care and Prevention in the United States (CAPUS) Demonstration Project (FOA # CDC-RFA-PS12-1210), information available at: http://www.cdc.gov/hiv/prevention/demonstration/capus/index.html
c. Applicants must have more than 10,000 adults and adolescents living with diagnosed HIV infection, year-end 2010, in their jurisdiction based on estimates in CDC’s HIV Surveillance. Report available at: http://www.cdc.gov/hiv/library/reports/surveillance/index.html
As of July 19, 2013, the eligible states are Massachusetts, Michigan, New York (excluding New York City), South Carolina, and Washington. The eligible local health departments are the District of Columbia, Los Angeles County, New York City, Philadelphia, and San Francisco (Table 1). State and local health departments are responsible for and have authority to conduct HIV surveillance and to provide linkage to HIV medical care for all HIV-infected individuals within their jurisdiction. Eligibility for this FOA is limited to state and local health departments because a critical component of this study includes the use of state and local health department surveillance data and the provision of field services by health department trained personnel with the relevant field services training to locate, contact, and provide assistance (i.e., appointment date and transport) to link people to HIV medical care.
Grant Announcement Contact: CDC Procurement and Grants Office (PGO) Technical Information Management Section (TIMS) Phone: 770-488-2700
TECHNICAL INFORMATION MANAGEMENT SECTION (TIMS)

Centers for Disease Control and Prevention 404-498-2015
Similar Government Grants: • Centers for Disease Control and Prevention Cooperative Re-Engagement Controlled Trial (CoR...; • Opportunity RFA-PS-11-003; • Screening Targeted Populations to Interrupt On-going Chains of Transmission with Enhanced ...; • Minority HIV/AIDS Research Initiative to Build Capacity in Black and Hispanic Communities ...; • Epidemiologic HIV/AIDS Research Among African American and Hispanic Women at Risk for HIV ...; • Rapid Strengthening of Blood Transfusion Services in Selected Countries in Africa and the ...; • Providing Techincal Assistance for the Rapid Strengthening of Blood Transfusion Services i...; • Capacity Building Assistance to Improve the Delivery and Effectiveness of Human Immunodefi...
More Grants from the Centers for Disease Control and Prevention: • Advancing Diagnostic Network Optimization, Stepwise Laboratory Accreditation, and Integrat...; • Strengthening Public Health Systems and Services through National Partnerships to Improve ...; • 93.067; • Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...; • Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...